HOME >> BIOLOGY >> NEWS
Livermore research team wins distinguished Department of Energy award for development of miniature glucose sensor for diabetes patients

ght Award is selected by a panel of DOE Citizen Judges, who choose innovations from among 23 discoveries or innovations hatched between 1999 and 2000. The innovations must demonstrate a benefit to the American public, be a contribution to U.S. competitiveness in the global marketplace and have the potential for significant future growth.

"We are extremely proud that DOE has selected one of the extraordinary achievements made by the Laboratory's Medical Technology Program team for the Bright Light Award," said Jeff Wadsworth, deputy director for Science and Technology. "This award proves the Laboratory continues to make significant contributions that benefit the quality of life."

The Bright Light Award is part of DOEs Energy 100 list, which honors 23 years of the best scientific and technological accomplishments the Department of Energy has to offer since the department was created in 1977. The achievements were nominated for review by DOE lab, program and field offices. A panel of citizen judges evaluated the achievements based on consumer orientation, whether it saves money and its ability to improve American quality of life.


'"/>

Contact: Anne Stark
stark8@llnl.gov
925-422-9799
DOE/Lawrence Livermore National Laboratory
7-Jan-2001


Page: 1 2

Related biology news :

1. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
2. Livermore & NIH scientists create technique to examine behavior of proteins at single molecule level
3. Livermore researchers apply combat simulation technology to homeland security
4. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
5. Lawrence Livermore research team finds unique DNA signatures to improve anthrax detection
6. Livermore Lab hosts conference on Bioterrorism for the Courts
7. Lawrence Livermore Lab, UC Davis Cancer Center ink alliance to develop integrated cancer program
8. UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products
9. Leader in cancer treatment and prevention research honored
10. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
11. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories

Post Your Comments:
(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
(Date:4/17/2014)... France have hit on a novel method to ... correct and most effective treatment possible., Kidney stones ... and developing world. If left untreated, apart from ... failure and other complications. In many patients treated ... a more effective pathological approach to diagnosis and ...
(Date:4/17/2014)... expression is the process whereby the genetic information ... such as proteins, which have numerous different functions ... an important intermediary during gene expression, by relating ... mechanisms involved in manufacturing proteins. , By ... molecules present in an organism at a given ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Rapid and accurate mRNA detection in plant tissues 2
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: